Compliance Policy Guide Sec. 560.400-Imported Milk and Cream-Federal Import Milk Act (Compliance Policy Guide 7119.05); Availability, 19489-19490 [05-7343]
Download as PDF
Federal Register / Vol. 70, No. 70 / Wednesday, April 13, 2005 / Notices
effectiveness of marketed and
investigational human drug products for
use in the treatment of dermatologic and
ophthalmic disorders and makes
appropriate recommendations to the
Commissioner.
E. Endocrinologic and Metabolic Drugs
Advisory Committee
The committee reviews and evaluates
data concerning the safety and
effectiveness of marketed and
investigational human drug products for
use in the treatment of endocrine and
metabolic disorders and makes
appropriate recommendations to the
Commissioner.
F. Nonprescription Drugs Advisory
Committee
The committee reviews and evaluates
available data concerning the safety and
effectiveness of over-the-counter
(nonprescription) human drug products,
or any other FDA-regulated product, for
use in the treatment of a broad spectrum
of human symptoms and diseases and
advises the Commissioner either on the
issuance of monographs establishing
conditions under which these drugs are
generally recognized as safe and
effective and not misbranded, or on the
approval of new drug applications for
such drugs. The committee serves as a
forum for the exchange of views
regarding the prescription and
nonprescription status, including
switches from one status to another, of
these various drug products and
combinations thereof. The committee
may also conduct peer review of agency
sponsored intramural and extramural
scientific biomedical programs in
support of FDA’s mission and regulatory
responsibilities.
G. Pulmonary-Allergy Drugs Advisory
Committee
The committee reviews and evaluates
available data concerning the safety and
effectiveness of marketed and
investigational human drug products for
use in the treatment of pulmonary
disease and diseases with allergic and/
or immunologic mechanisms and makes
appropriate recommendations to the
Commissioner.
II. Criteria for Members
Persons who are nominated for
membership on the committees as
consumer representatives must meet the
following criteria: (1) Demonstrate ties
to consumer and community-based
organizations, (2) be able to analyze
technical data, (3) understand research
design, (4) discuss benefits and risks,
and (5) evaluate the safety and efficacy
of products under review. The
VerDate jul<14>2003
18:37 Apr 12, 2005
Jkt 205001
19489
consumer representative must be able to
represent the consumer perspective on
issues and actions before the advisory
committee; serve as a liaison between
the committee and interested
consumers, associations, coalitions, and
consumer organizations; and facilitate
dialogue with the advisory committees
on scientific issues that affect
consumers.
Compliance Policy Guide Sec.
560.400—Imported Milk and Cream—
Federal Import Milk Act (Compliance
Policy Guide 7119.05); Availability
III. Selection Procedures
AGENCY:
The selection of members
representing consumer interests is
conducted through procedures that
include the use of organizations
representing the public interest and
consumer advocacy groups. The
organizations have the responsibility of
recommending candidates of the
agency’s selection.
ACTION:
All nominations must include a cover
letter, a curriculum vitae or resume (that
includes the nominee’s office address,
telephone number, and e-mail address),
and a list of consumer or communitybased organizations for which the
candidate can demonstrate active
participation.
Any interested person or organization
may nominate one or more qualified
persons for membership on one or more
of the advisory committees to represent
consumer interests. Self-nominations
are also accepted. FDA will ask the
potential candidates to provide detailed
information concerning such matters as
financial holdings, employment, and
research grants and/or contracts to
permit evaluation of possible sources of
a conflict of interest. The nomination
should specify the committee(s) of
interest. The term of office is up to 4
years, depending on the appointment
date.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: April 1, 2005.
Sheila Dearybury Walcoff,
Associate Commissioner for External
Relations.
[FR Doc. 05–7342 Filed 4–12–05; 8:45 am]
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Food and Drug Administration
[Docket No. 2004D–0453]
Food and Drug Administration,
HHS.
IV. Nomination Procedures
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a compliance policy
guide (CPG) entitled ‘‘Sec. 560.400—
Imported Milk and Cream—Federal
Import Milk Act (CPG 7119.05).’’ The
CPG provides guidance on the
applicability of the Federal Import Milk
Act (FIMA) to imported milk and cream.
This document updates the existing
CPG.
Submit written or electronic
comments concerning the CPG or the
supporting document at any time.
ADDRESSES: Submit written requests for
single copies of the CPG entitled ‘‘Sec.
560.400—Imported Milk and Cream—
Federal Import Milk Act (CPG 7119.05)’’
to the Division of Compliance Policy
(HFC–230), Office of Enforcement,
Office of Regulatory Affairs, Food and
Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857. Send two
self-addressed adhesive labels to assist
that office in processing your request, or
fax your request to 240–632–6861. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the document.
Submit written comments on the
revised CPG to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT:
Esther Lazar, Center for Food Safety and
Applied Nutrition (HFS–306), Food and
Drug Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740–3835,
301–436–1485, FAX: 301–436–2632.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background
In the Federal Register of October 29,
2004 (69 FR 63158), FDA announced the
availability of a draft CPG entitled ‘‘Sec.
560.400—Imported Milk and Cream—
Federal Import Milk Act (CPG
7119.05).’’ After considering comments
received, FDA has finalized the CPG.
The CPG updates and replaces ‘‘CPG
Sec. 560.400—Imported Milk and
E:\FR\FM\13APN1.SGM
13APN1
19490
Federal Register / Vol. 70, No. 70 / Wednesday, April 13, 2005 / Notices
Cream—Import Milk Act (CPG
7119.05).’’
FDA received 10 comments on the
draft CPG. The comments represented
the views of individual consumers,
industry, and industry trade
representatives. One comment requested
clarification on whether sweetened
condensed milk was subject to a FIMA
permit. Nine comments were outside
the scope of the draft CPG. After
considering carefully the relevant
comment received, FDA revised its
intended treatment of sweetened
condensed milk and evaporated milk
under the FIMA. Accordingly, under
Section III.B. of the CPG, ‘‘Application
of the FIMA:,’’ the following changes
were made:
• In paragraph 1.i. of the CPG, we
removed ‘‘Sweetened Condensed Milk’’
and ‘‘Evaporated Milk’’ from the list of
products that FDA intends to consider
as subject to the FIMA’s permit
requirements for importation; and
• In paragraph 2.ii. of the CPG, we
added ‘‘Sweetened Condensed Milk’’
and ‘‘Evaporated Milk’’ to the list of
products that FDA intends to consider
as not subject to the FIMA’s permit
requirements for importation.
We also edited the CPG to clarify the
following:
• In section II of the CPG, regulations
under the FIMA are found in 21 CFR
part 1210;
• In section II of the CPG, FDA
intends to consider sweetened
condensed milk and evaporated milk as
not subject to the provisions of the
FIMA. Sweetened condensed milk is
required by § 131.120 (21 CFR 131.120)
to contain a quantity of nutritive
carbohydrate sweetener sufficient to
prevent spoilage, and evaporated milk is
required by § 131.130 to be sealed in a
container and so processed by heat as to
prevent spoilage;
• In section III of the CPG, FDA
intends to consider ‘‘Nonfat Milk’’ as
subject to the FIMA’s permit
requirement for importation; and
• In section V of the CPG, the
specimen charge should be worded,
‘‘The article of [milk] [cream] is not
accompanied by a valid import milk
permit, as required by the Federal
Import Milk Act (21 U.S.C. 141–149).’’
The CPG is being issued as level 1
guidance consistent with FDA’s good
guidance practices regulation (21 CFR
10.115). The CPG represents the
agency’s current thinking on its
enforcement process concerning the
FIMA. It does not create or confer any
rights for or on any person and does not
operate to bind FDA or the public.
VerDate jul<14>2003
18:37 Apr 12, 2005
Jkt 205001
II. Comments
Subject name, address
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4.p.m., Monday through Friday.
III. Electronic Access
An electronic version of the revised
CPG is available on the Internet at http:/
/www.fda.gov/ora under ‘‘Compliance
References.’’
Dated: March 30, 2005.
John R. Marzilli,
Deputy Associate Commissioner for
Regulatory Affairs.
[FR Doc. 05–7343 Filed 4–12–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Inspector General
Program Exclusions: March 2005
AGENCY:
Office of Inspector General,
HHS.
ACTION:
Notice of program exclusions.
During the month of March 2005, the
HHS Office of Inspector General
imposed exclusions in the cases set
forth below. When an exclusions is
imposed, no program payment is made
to anyone for any items or services
(other than an emergency item or
service not provided in a hospital
emergency room) furnished, ordered or
prescribed by an excluded party under
the Medicare, Medicaid, and all Federal
Health Care programs. In addition, no
program payment is made to any
business or facility, e.g., a hospital, that
submits bills for payment for items or
services provided by an excluded party.
Program beneficiaries remain free to
decide for themselves whether they will
continue to use the services of an
excluded party even though no program
payments will be made for items and
services provided by that excluded
party. The exclusions have national
effect and also apply to all Executive
Branch procurement and nonprocurement programs and activities.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Effective
date
PROGRAM-RELATED CONVICTIONS
ALLEN, SHARON .....................
LIVINGSTON, TN
ARTHUR C O’BRIEN MD, INC
HAYWARD, CA
AUGUSTINE, SCOTT ..............
BLOMMINGTON, MN
BAINBRIDGE MANAGEMENT
CHICAGO, IL
BEILHARZ, JOYCE ..................
HILLIARD, OH
BENHAM, JAMES ....................
NORTH OAKS, MN
BLUE, FELICIA .........................
DUNN, NC
BRADDOCK MANAGEMENT
LP ..........................................
CHICAGO, IL
CHEATAM, MARION ................
REYNOLDSBURY, OH
CORRAI, ANNIE .......................
MARYSVILLE, OH
CORRAL, EDMOND .................
LOS ANGELES, CA
CUBRIA, ANDREW ..................
LISBON, OH
DIAZ, BLAS ..............................
LOS ANGELES, CA
EDOHO-UKWA, ANIETIE ........
MCKINNEY, TX
EDOHO-UKWA, UKWA ............
FRISCO, TX
ELLIS, CRISTINA .....................
FONTANA, CA
FLEISCHER, MARK .................
OTISVILLE, NY
FOREMAN, PAUL ....................
COLUMBIA, MO
GARADA, HAZEM ....................
MORGANTOWN, WV
GRAYSON, CYNTHIA ..............
BATON ROUGE, LA
GREENWALD, BRUCE ............
ST LOUIS, MO
HEALTH CARE 2000, INC .......
CHAVIES, KY
HOWARD, ANNIESA ...............
REYNOLDSBURG, OH
J & J SLEEP, INC ....................
NEW PORT RICHEY, FL
JAPSON, SUSANNE ................
BROOKHAVEN, NY
JETTER, RODNEY ...................
CINCINNATI, OH
JORDAN, LAKESHA ................
SPENCER, NC
JUN, DINA ................................
LONG BEACH, CA
KARKOTSYAN, KIRAKOS .......
LONG BEACH, CA
KINGEN, JACK .........................
NEW PORT RICHEY, FL
KIRPICHYAN, HAKOP .............
VAN NUYS, CA
KLEBER, PENNI ......................
PORTLAND, OR
KOPP, RUTH ............................
EDELSTEIN, IL
KRAJIAN, JOHN .......................
BEVERLY HILLS, CA
KUYKENDALL, PAMELA .........
COOS BAY, OR
LATONN, EDWARD .................
E:\FR\FM\13APN1.SGM
13APN1
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
4/20/2005
Agencies
[Federal Register Volume 70, Number 70 (Wednesday, April 13, 2005)]
[Notices]
[Pages 19489-19490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7343]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004D-0453]
Compliance Policy Guide Sec. 560.400--Imported Milk and Cream--
Federal Import Milk Act (Compliance Policy Guide 7119.05); Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a compliance policy guide (CPG) entitled ``Sec.
560.400--Imported Milk and Cream--Federal Import Milk Act (CPG
7119.05).'' The CPG provides guidance on the applicability of the
Federal Import Milk Act (FIMA) to imported milk and cream. This
document updates the existing CPG.
DATES: Submit written or electronic comments concerning the CPG or the
supporting document at any time.
ADDRESSES: Submit written requests for single copies of the CPG
entitled ``Sec. 560.400--Imported Milk and Cream--Federal Import Milk
Act (CPG 7119.05)'' to the Division of Compliance Policy (HFC-230),
Office of Enforcement, Office of Regulatory Affairs, Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857. Send two self-
addressed adhesive labels to assist that office in processing your
request, or fax your request to 240-632-6861. See the SUPPLEMENTARY
INFORMATION section for electronic access to the document.
Submit written comments on the revised CPG to the Division of
Dockets Management (HFA-305), Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments
to https://www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT: Esther Lazar, Center for Food Safety
and Applied Nutrition (HFS-306), Food and Drug Administration, 5100
Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-1485, FAX:
301-436-2632.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of October 29, 2004 (69 FR 63158), FDA
announced the availability of a draft CPG entitled ``Sec. 560.400--
Imported Milk and Cream--Federal Import Milk Act (CPG 7119.05).'' After
considering comments received, FDA has finalized the CPG. The CPG
updates and replaces ``CPG Sec. 560.400--Imported Milk and
[[Page 19490]]
Cream--Import Milk Act (CPG 7119.05).''
FDA received 10 comments on the draft CPG. The comments represented
the views of individual consumers, industry, and industry trade
representatives. One comment requested clarification on whether
sweetened condensed milk was subject to a FIMA permit. Nine comments
were outside the scope of the draft CPG. After considering carefully
the relevant comment received, FDA revised its intended treatment of
sweetened condensed milk and evaporated milk under the FIMA.
Accordingly, under Section III.B. of the CPG, ``Application of the
FIMA:,'' the following changes were made:
In paragraph 1.i. of the CPG, we removed ``Sweetened
Condensed Milk'' and ``Evaporated Milk'' from the list of products that
FDA intends to consider as subject to the FIMA's permit requirements
for importation; and
In paragraph 2.ii. of the CPG, we added ``Sweetened
Condensed Milk'' and ``Evaporated Milk'' to the list of products that
FDA intends to consider as not subject to the FIMA's permit
requirements for importation.
We also edited the CPG to clarify the following:
In section II of the CPG, regulations under the FIMA are
found in 21 CFR part 1210;
In section II of the CPG, FDA intends to consider
sweetened condensed milk and evaporated milk as not subject to the
provisions of the FIMA. Sweetened condensed milk is required by Sec.
131.120 (21 CFR 131.120) to contain a quantity of nutritive
carbohydrate sweetener sufficient to prevent spoilage, and evaporated
milk is required by Sec. 131.130 to be sealed in a container and so
processed by heat as to prevent spoilage;
In section III of the CPG, FDA intends to consider
``Nonfat Milk'' as subject to the FIMA's permit requirement for
importation; and
In section V of the CPG, the specimen charge should be
worded, ``The article of [milk] [cream] is not accompanied by a valid
import milk permit, as required by the Federal Import Milk Act (21
U.S.C. 141-149).''
The CPG is being issued as level 1 guidance consistent with FDA's
good guidance practices regulation (21 CFR 10.115). The CPG represents
the agency's current thinking on its enforcement process concerning the
FIMA. It does not create or confer any rights for or on any person and
does not operate to bind FDA or the public.
II. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments regarding this document.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4.p.m., Monday
through Friday.
III. Electronic Access
An electronic version of the revised CPG is available on the
Internet at https://www.fda.gov/ora under ``Compliance References.''
Dated: March 30, 2005.
John R. Marzilli,
Deputy Associate Commissioner for Regulatory Affairs.
[FR Doc. 05-7343 Filed 4-12-05; 8:45 am]
BILLING CODE 4160-01-S